ArticleBMC microbiology2026
Phenotypic and genotypic characterization of clinical plasmid-mediated quinolone resistance (PMQR) and extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales in two healthcare facilities in Douala, Cameroon.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence and escalation of antibiotic resistance in community and hospital settings remain a major public health concern worldwide. The co-occurrence of fluoroquinolone resistance in extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), which are responsible for life-threatening infectious diseases, poses a critical threat, leading to increase therapeutic costs, prolonged hospital stays, and higher mortality rates, particularly in low- and middle-income countries (LMICs) like Cameroon. Given the lack of data regarding the co-occurrence of plasmid-mediated quinolone resistance (PMQR) among ESBL-E responsible for infectious diseases in Cameroon, this study aims at determining the prevalence, phenotypic and genotypic characterization of PMQR among ESBL-Enterobacterales isolated from clinical samples in two healthcare facilities in Douala, Cameroon. MATERIAL AND
methodsOut of 1,139 non-repetitive clinical samples collected from patients, a total of 140 Enterobacterales were identified from February to May 2024. Identification was done using API20E. ESBL screening was performed using the double-disk synergy test and Chromogenic ESBL Agar. Antimicrobial susceptibility testing was done using a Kirby Bauer Disc Diffusion method. Conventional and multiplex PCR were done for the detection of PMQR and ESBL genes.
resultsOf the different clinical samples collected, Enterobacterales were most isolated from urine (57.1%), endocervical swabs (12.9%), wounds (12.9%), and blood (9.3%). Out of 140 non-duplicate Enterobacterales, the predominant species were Escherichia coli (60/140; 42.9%) and Klebsiella pneumoniae (50/140; 35.7%). The prevalence of ESBL-producing Enterobacterales (ESBL-E) was 64%. Among all ESBL-E, 81.1% and 94.4% were fluoroquinolone and multi-drug resistant (MDR) respectively. The bla
conclusionThis study reveals a high prevalence of PMQR among ESBL-producing Enterobacterales in two healthcare facilities in Douala, Cameroon. It also showed that hospitalized patients were more infected than outpatients, suggesting the need to reinforce infection prevention and control measures (IPC). The high prevalence of resistance genes observed among these strains underlines the excessive antibiotic use, highlighting the urgent need for rigorous surveillance systems and the implementation of antimicrobial stewardship (AMS) in these healthcare facilities. An integrated, proactive, and real-time genomic surveillance of AMR is crucial to curb the dissemination of these bacterial AMR in hospital and community settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.